Literature DB >> 17962861

Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment.

Rosana Bihari Schechter1, Eponina Maria Oliveira Lemme, Henrique Sérgio Moraes Coelho.   

Abstract

BACKGROUND: Portal hypertension in patients with liver cirrhosis causes manifestations such as esophageal varices, ascites and edema. Some studies have been conducted about the role of esophageal varices in the development of esophageal motor disorders and abnormal gastroesophageal reflux in these patients. Ascites could be a factor promoting gastroesophageal reflux and it has been questioned whether reflux would favor the rupture of varices. However there are a few studies using ambulatory esophageal pH recording in the evaluation of these patients. AIMS: Evaluate gastroesophageal reflux by pH recording in cirrhotic patients with esophageal varices and possible predictors.
METHODS: Fifty one patients (28 men, 23 women, mean age of 54 years) with liver cirrhosis, diagnosed by clinical, laboratorial, image and histological findings were prospectively evaluated. All patients had esophageal varices confirmed by endoscopy and were submitted to a questionnaire about typical gastroesophageal reflux disease symptoms (heartburn and or acid regurgitation). pH recording was performed with the probe placed 5 cm above the superior lower esophageal sphincter limit, as determined by manometry. Abnormal reflux (% total time with pH < 4 >4.5%) was related to the size of varices, congestive gastropathy, ascites, severity of cirrhosis and typical gastroesophageal reflux disease symptoms.
RESULTS: The caliber of the varices was considered to be small in 30 patients (59%), medium in 17 (33%) and large in 4 (8%), 21 (41%) congestive gastropathy. Ascites was observed in 17 (33%), 32 patients (63%) were classified as Child-Pugh A, 17 (33%) Child-Pugh B and 2 (4%) Child-Pugh C. Twenty seven patients (53%) presented with typical gastroesophageal reflux disease symptoms. Abnormal reflux at pH recording was found in 19 patients (37%). One of them presented with erosive esophagitis at endoscopy. There was no relation between ascites, variceal size, congestive gastropathy and Child-Pugh score and abnormal reflux. There was a correlation between typical gastroesophageal reflux disease symptoms and abnormal reflux.
CONCLUSION: Abnormal gastroesophageal reflux was found in 37% of the patients with hepatic cirrhosis and esophageal varices. Only typical gastroesophageal reflux disease symptoms predicted these findings.

Entities:  

Mesh:

Year:  2007        PMID: 17962861     DOI: 10.1590/s0004-28032007000200012

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  7 in total

1.  Gastroesophageal Reflux-Is It Uncommon in Indian Patients With Decompensated Liver Cirrhosis?

Authors:  Uday Sanglodkar; Mayank Jain; M J Alexander; Jayanthi Venkataraman
Journal:  J Clin Exp Hepatol       Date:  2018-10-05

2.  Gastroesophageal reflux in cirrhotic patients without esophageal varices.

Authors:  Jun Zhang; Pei-Lin Cui; Dong Lv; Shi-Wei Yao; You-Qing Xu; Zhao-Xu Yang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  High prevalence of reflux esophagitis among upper endoscopies in Chinese patients with chronic liver diseases.

Authors:  Bing Li; Bin Zhang; Jun Wei Ma; Peng Li; Lei Li; Yun Ming Song; Hui Guo Ding
Journal:  BMC Gastroenterol       Date:  2010-06-04       Impact factor: 3.067

Review 4.  Asymmetrical circumferential distribution of esophagogastric junctional lesions: anatomical and physiological considerations.

Authors:  Yoshikazu Kinoshita; Kenji Furuta; Kyoichi Adachi; Yuji Amano
Journal:  J Gastroenterol       Date:  2009-06-13       Impact factor: 7.527

5.  Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal reflux disease: a multicentre, cross-sectional study in Pakistan.

Authors:  Ibrahim Warsi; Javeria Ahmed; Anjum Younus; Abdur Rasheed; Tayyab Saeed Akhtar; Qurrat Ul Ain; Zohaib Khurshid
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

6.  Risk of progression of Barrett's esophagus in patients with cirrhosis.

Authors:  Tehilla Apfel; Rocio Lopez; Madhusudhan R Sanaka; Prashanthi N Thota
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

7.  Safety and efficacy of risedronate for patients with esophageal varices and liver cirrhosis: a non-randomized clinical trial.

Authors:  Talles Bazeia Lima; Lívia Alves Amaral Santos; Hélio Rubens de Carvalho Nunes; Giovanni Faria Silva; Carlos Antonio Caramori; Xingshun Qi; Fernando Gomes Romeiro
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.